Logo image of SGHC

SUPER GROUP SGHC LTD (SGHC) Stock Fundamental Analysis

USA - NYSE:SGHC - GG00BMG42V42 - Common Stock

13.3 USD
+0.28 (+2.15%)
Last: 9/26/2025, 8:04:01 PM
13.3 USD
0 (0%)
After Hours: 9/26/2025, 8:04:01 PM
Fundamental Rating

6

Taking everything into account, SGHC scores 6 out of 10 in our fundamental rating. SGHC was compared to 134 industry peers in the Hotels, Restaurants & Leisure industry. SGHC has an average financial health and profitability rating. SGHC is growing strongly while it is still valued neutral. This is a good combination! This makes SGHC very considerable for growth investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year SGHC was profitable.
SGHC had positive earnings in 4 of the past 5 years.
In the past 5 years SGHC always reported a positive cash flow from operatings.
SGHC Yearly Net Income VS EBIT VS OCF VS FCFSGHC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

1.2 Ratios

SGHC's Return On Assets of 12.53% is amongst the best of the industry. SGHC outperforms 89.55% of its industry peers.
SGHC has a Return On Equity of 21.09%. This is in the better half of the industry: SGHC outperforms 79.85% of its industry peers.
SGHC's Return On Invested Capital of 30.55% is amongst the best of the industry. SGHC outperforms 97.01% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for SGHC is in line with the industry average of 15.67%.
The 3 year average ROIC (15.79%) for SGHC is below the current ROIC(30.55%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.53%
ROE 21.09%
ROIC 30.55%
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
SGHC Yearly ROA, ROE, ROICSGHC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 50 100 150

1.3 Margins

SGHC has a better Profit Margin (7.02%) than 61.94% of its industry peers.
SGHC's Profit Margin has declined in the last couple of years.
SGHC's Operating Margin of 14.22% is fine compared to the rest of the industry. SGHC outperforms 67.91% of its industry peers.
SGHC's Operating Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.22%
PM (TTM) 7.02%
GM N/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SGHC Yearly Profit, Operating, Gross MarginsSGHC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

More info and screens

5

2. Health

2.1 Basic Checks

SGHC has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SGHC has more shares outstanding than it did 1 year ago.
SGHC has more shares outstanding than it did 5 years ago.
SGHC has a worse debt/assets ratio than last year.
SGHC Yearly Shares OutstandingSGHC Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
SGHC Yearly Total Debt VS Total AssetsSGHC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.2 Solvency

SGHC has an Altman-Z score of 12.18. This indicates that SGHC is financially healthy and has little risk of bankruptcy at the moment.
SGHC has a Altman-Z score of 12.18. This is amongst the best in the industry. SGHC outperforms 97.01% of its industry peers.
SGHC has a Debt/Equity ratio of 0.11. This is a healthy value indicating a solid balance between debt and equity.
SGHC's Debt to Equity ratio of 0.11 is amongst the best of the industry. SGHC outperforms 81.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Altman-Z 12.18
ROIC/WACC3.44
WACC8.88%
SGHC Yearly LT Debt VS Equity VS FCFSGHC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 0 200M 400M

2.3 Liquidity

SGHC has a Current Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a Current ratio of 1.42. This is in the better half of the industry: SGHC outperforms 70.90% of its industry peers.
SGHC has a Quick Ratio of 1.42. This is a normal value and indicates that SGHC is financially healthy and should not expect problems in meeting its short term obligations.
SGHC has a better Quick ratio (1.42) than 73.13% of its industry peers.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
SGHC Yearly Current Assets VS Current LiabilitesSGHC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 127.13% over the past year.
Measured over the past years, SGHC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -21.17% on average per year.
Looking at the last year, SGHC shows a quite strong growth in Revenue. The Revenue has grown by 18.20% in the last year.
SGHC shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 28.06% yearly.
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%41.7%

3.2 Future

The Earnings Per Share is expected to grow by 40.64% on average over the next years. This is a very strong growth
SGHC is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.50% yearly.
EPS Next Y56.69%
EPS Next 2Y54.6%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue Next Year25.65%
Revenue Next 2Y16.16%
Revenue Next 3Y13.5%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
SGHC Yearly Revenue VS EstimatesSGHC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
SGHC Yearly EPS VS EstimatesSGHC Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 44.33, the valuation of SGHC can be described as expensive.
SGHC's Price/Earnings ratio is in line with the industry average.
The average S&P500 Price/Earnings ratio is at 27.32. SGHC is valued rather expensively when compared to this.
SGHC is valuated rather expensively with a Price/Forward Earnings ratio of 18.84.
Based on the Price/Forward Earnings ratio, SGHC is valued a bit cheaper than the industry average as 63.43% of the companies are valued more expensively.
SGHC's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.89.
Industry RankSector Rank
PE 44.33
Fwd PE 18.84
SGHC Price Earnings VS Forward Price EarningsSGHC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of SGHC is on the same level as its industry peers.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 17.53
SGHC Per share dataSGHC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of SGHC may justify a higher PE ratio.
SGHC's earnings are expected to grow with 40.64% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.78
PEG (5Y)N/A
EPS Next 2Y54.6%
EPS Next 3Y40.64%

More info and screens

2

5. Dividend

5.1 Amount

SGHC has a Yearly Dividend Yield of 1.23%. Purely for dividend investing, there may be better candidates out there.
SGHC's Dividend Yield is a higher than the industry average which is at 6.79.
Compared to an average S&P500 Dividend Yield of 2.38, SGHC's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 1.23%

5.2 History

SGHC does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
SGHC Yearly Dividends per shareSGHC Yearly Dividends per shareYearly Dividends per share 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

DPN/A
EPS Next 2Y54.6%
EPS Next 3Y40.64%
SGHC Yearly Income VS Free CF VS DividendSGHC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2019 2020 2021 2022 2023 2024 0 50M 100M 150M 200M 250M

More info and screens

SUPER GROUP SGHC LTD

NYSE:SGHC (9/26/2025, 8:04:01 PM)

After market: 13.3 0 (0%)

13.3

+0.28 (+2.15%)

Chartmill FA Rating
GICS IndustryGroupConsumer Services
GICS IndustryHotels, Restaurants & Leisure
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-04 2025-11-04
Inst Owners11.19%
Inst Owner Change26.99%
Ins Owners4.59%
Ins Owner ChangeN/A
Market Cap6.73B
Analysts84.62
Price Target15.74 (18.35%)
Short Float %4.83%
Short Ratio3.4
Dividend
Industry RankSector Rank
Dividend Yield 1.23%
Yearly Dividend0.1
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-Date09-18 2025-09-18 (0.04)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-6.39%
Min EPS beat(2)-23.38%
Max EPS beat(2)10.61%
EPS beat(4)2
Avg EPS beat(4)-4.12%
Min EPS beat(4)-24.38%
Max EPS beat(4)20.66%
EPS beat(8)4
Avg EPS beat(8)52.32%
EPS beat(12)5
Avg EPS beat(12)27.24%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)3.51%
Min Revenue beat(2)-1.09%
Max Revenue beat(2)8.12%
Revenue beat(4)2
Avg Revenue beat(4)2.66%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)8.12%
Revenue beat(8)6
Avg Revenue beat(8)4.69%
Revenue beat(12)9
Avg Revenue beat(12)4.83%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)9.09%
PT rev (3m)30.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)17.26%
EPS NY rev (1m)0%
EPS NY rev (3m)-16.93%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)3.66%
Revenue NY rev (1m)3.14%
Revenue NY rev (3m)3.94%
Valuation
Industry RankSector Rank
PE 44.33
Fwd PE 18.84
P/S 3.47
P/FCF N/A
P/OCF N/A
P/B 10.43
P/tB 18.68
EV/EBITDA 17.53
EPS(TTM)0.3
EY2.26%
EPS(NY)0.71
Fwd EY5.31%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS3.83
BVpS1.28
TBVpS0.71
PEG (NY)0.78
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 12.53%
ROE 21.09%
ROCE 38.67%
ROIC 30.55%
ROICexc 60.17%
ROICexgc 282.89%
OM 14.22%
PM (TTM) 7.02%
GM N/A
FCFM N/A
ROA(3y)10.16%
ROA(5y)16.96%
ROE(3y)17.87%
ROE(5y)59.56%
ROIC(3y)15.79%
ROIC(5y)31.82%
ROICexc(3y)34.14%
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)19.99%
ROCE(5y)40.28%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-1.96%
ROICexc growth 5YN/A
OM growth 3Y-8.81%
OM growth 5YN/A
PM growth 3Y-28%
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover1.79
Health
Industry RankSector Rank
Debt/Equity 0.11
Debt/FCF N/A
Debt/EBITDA 0.19
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z 12.18
F-ScoreN/A
WACC8.88%
ROIC/WACC3.44
Cap/Depr(3y)74.88%
Cap/Depr(5y)56.11%
Cap/Sales(3y)3.76%
Cap/Sales(5y)2.95%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)127.13%
EPS 3Y-21.17%
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y56.69%
EPS Next 2Y54.6%
EPS Next 3Y40.64%
EPS Next 5YN/A
Revenue 1Y (TTM)18.2%
Revenue growth 3Y5.54%
Revenue growth 5Y28.06%
Sales Q2Q%41.7%
Revenue Next Year25.65%
Revenue Next 2Y16.16%
Revenue Next 3Y13.5%
Revenue Next 5YN/A
EBIT growth 1Y187.07%
EBIT growth 3Y-3.76%
EBIT growth 5YN/A
EBIT Next Year99.73%
EBIT Next 3Y36.11%
EBIT Next 5YN/A
FCF growth 1Y142.01%
FCF growth 3Y-1.1%
FCF growth 5Y295.28%
OCF growth 1Y113.54%
OCF growth 3Y7.33%
OCF growth 5Y137.97%